Cutaneous Pseudolymphoma.
Mitteldorf C, Kempf W.
Surg Pathol Clin. 2017 Jun;10(2):455-476. doi: 10.1016/j.path.2017.01.002. Epub 2017 Mar 22.
Cutaneous pseudolymphoma-A review on the spectrum and a proposal for a new classification.
Mitteldorf C, Kempf W.
J Cutan Pathol. 2020 Jan;47(1):76-97. doi: 10.1111/cup.13532. Epub 2019 Jul 31.
Lithium-Induced Cutaneous Pseudolymphoma.
Lee Y.
Alpha Psychiatry. 2023 Jan 1;24(1):34-35. doi: 10.5152/alphapsychiatry.2023.221037. eCollection 2023 Jan.
Drug-induced cutaneous pseudolymphoma: A systematic review of the literature.
Etesami I, Kalantari Y, Tavakolpour S, Mahmoudi H, Daneshpazhooh M.
Australas J Dermatol. 2023 Feb;64(1):41-49. doi: 10.1111/ajd.13951. Epub 2022 Nov 4.
Cutaneous pseudolymphoma successfully treated with dupilumab.
Sugiura S, Nakanishi T, Fujimoto N.
Eur J Dermatol. 2023 Jun 1;33(3):307-309. doi: 10.1684/ejd.2023.4482.
Lamotrigine-induced cutaneous pseudolymphoma.
Reed KL, Quinn KB, Gust AJ.
Cutis. 2019 Aug;104(2):E1-E3.
Treatment of Cutaneous Pseudolymphoma: A Systematic Review.
Miguel D, Peckruhn M, Elsner P.
Acta Derm Venereol. 2018 Mar 13;98(3):310-317. doi: 10.2340/00015555-2841.
Cutaneous Pseudolymphomas.
Romero-Pérez D, Blanes Martínez M, Encabo-Durán B.
Actas Dermosifiliogr. 2016 Oct;107(8):640-51. doi: 10.1016/j.ad.2016.05.003. Epub 2016 Jun 8.
Cutaneous pseudolymphoma following sub-cutaneous immunotherapy for dust mites.
Badaoui A, Moulonguet I.
Ann Dermatol Venereol. 2023 Dec;150(4):312-313. doi: 10.1016/j.annder.2023.09.002. Epub 2023 Nov 11.
Paraphenylenediamine-induced Cutaneous Pseudolymphoma.
Sequeira FF, Jayaseelan E, Stephen J.
Indian J Dermatol. 2014 Jul;59(4):424. doi: 10.4103/0019-5154.135562.
